ADMA Biologics, Inc.

ADMA US Health Care Biotechnology
S&P 600
$9.23
-1.70%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does ADMA Biologics, Inc. belong to?
ADMA Biologics, Inc. operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of ADMA?
As of the latest available quote, ADMA traded at $9.23. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of ADMA?
ADMA Biologics, Inc. has a price-to-earnings (P/E) ratio of about 13.19. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of ADMA?
The market capitalisation of ADMA Biologics, Inc. is approximately $2.26B.
Is ADMA Biologics, Inc. profitable?
For its latest reported financial year, ADMA Biologics, Inc. recorded a net profit margin of about 28.80%.
Does ADMA pay a dividend?
ADMA Biologics, Inc. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of ADMA?
ADMA Biologics, Inc. has a return on equity (ROE) of about 35.99%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of ADMA?
Over the past 52 weeks, ADMA has traded between a low of $7.21 and a high of $20.46.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.